MedPath

Multidimensional evaluation of the effectiveness of Early Voice Therapy Protocol on the voice of patients with Early Laryngeal Carcinoma after Transoral Laser Microsurgery (TLM)

Not Applicable
Conditions
aryngeal Carcinoma.
Malignant neoplasm of glottis
C32.0
Registration Number
IRCT20210131050187N1
Lead Sponsor
Research Deputy of University of Social welfare and Rehabilitation Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
24
Inclusion Criteria

Willingness to participate in research
Age range 18 to 65 years
Infection with unilateral or bilateral malignant tumors of the Glottis Area
Being at stage zero, 1 or 2 tumor growth
No metastasis to lymph nodes and other parts of the body
Not receiving other oncological treatments (such as radiation, hormones and chemotherapy) before or at the same time as the research period
Do not participate in other courses of voice therapy after oncology treatment to improve voice disorder
A maximum of 3 days have elapsed since the completion of the laser surgery
Ability to read and write
No cognitive problems
No diabetes
No drug use
Do not use alcohol

Exclusion Criteria

Advanced laryngeal cancer
Receiving parallel and simultaneous other oncological treatments such as radiotherapy and chemotherapy
The presence of malignant cells in other parts of the larynx and body except the pelvis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath